English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/17987
Título

Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice

AutorCerdá, Begoña; Llorach, Rafael; Cerón, José J.; Espín de Gea, Juan Carlos ; Tomás Barberán, Francisco
Palabras claveEllagitannin
Punicalagin
Pomegranate juice
Bioavailability
Metabolism
Rat
Plasma
Urine
Faeces
HPLC-MS-MS
Fecha de publicación1-feb-2003
EditorSpringer
CitaciónEuropean Journal of Nutrition 42(1): 18-28 (2003)
Resumen[Background and Aims]: Punicalagin is an antioxidant ellagitannin of pomegranate juice. This compound is responsible for the high antioxidant activity of this juice. Nothing is known about the bioavailability and metabolism of punicalagin or other food ellagitannins. The present work aims to evaluate the bioavailability and metabolism of punicalagin in the rat as an animal model.
[Design]: Two groups of rats were studied. One fed with standard rat diet (n = 5) and another with the same diet plus 6 % punicalagin (n = 5). Samples of urine and faeces were taken during 37 days and plasma every week. The different metabolites were analysed by HPLC-MS-MS.
[Results]: The daily intake of punicalagin ranged from 0.6 to 1.2 g. Values around 3–6 % the ingested punicalagin were excreted as identified metabolites in faeces and urine. In faeces, punicalagin is transformed to hydrolysis products and partly metabolites by the rat microflora to 6H-dibenzo[b,d]pyran-6-one derivatives. In plasma, punicalagin was detected at concentrations around 30 μg/mL, and glucuronides of methyl ether derivatives of ellagic acid were also detected. 6H-Dibenzo[b,d]pyran-6-one derivatives were also detected especially during the last few weeks of the experiment. In urine, the main metabolites observed were the 6H-dibenzo[b,d]pyran-6-one derivatives, as aglycones or glucuronides.
[Conclusion]: As only 3–6 % of the ingested punicalagin was detected as such or as metabolites in urine and faeces, the majority of this ellagitannin has to be converted to undetectable metabolites (i. e. CO2) or accumulated in non-analysed tissues, however with only traces of punicalagin metabolites being detected in liver or kidney. This is the first report on the absorption of an ellagitannin and its presence in plasma. In addition, the transformation of ellagic acid derivatives to 6H-dibenzo[b,d]pyran-6-one derivatives in the rat is also confirmed.
Descripción11 pages, 10 figures, 1 table.
Versión del editorhttp://dx.doi.org/10.1007/s00394-003-0396-4
URIhttp://hdl.handle.net/10261/17987
DOI10.1007/s00394-003-0396-4
ISSN1436-6207 (Print)
1436-6215 (Online)
Aparece en las colecciones: (CEBAS) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.